tiprankstipranks
Trulieve Cannabis (TRLV)
NYSE:TRLV
US Market
TRLV
Trulieve Cannabis
RESEARCH TOOLSreports
Want to see TRLV full AI Analyst Report?

Trulieve Cannabis (TRLV) Stock Forecast & Price Target

2,791 Followers
See the Price Targets and Ratings of:

TRLV Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Trulieve
Cannabis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TRLV Stock 12 Month Forecast

Average Price Target

$18.67
▲(201.58% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Trulieve Cannabis in the last 3 months. The average price target is $18.67 with a high forecast of $19.73 and a low forecast of $16.91. The average price target represents a 201.58% change from the last price of $6.19.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","11":"$11","20":"$20","6.5":"$6.5","15.5":"$15.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.731516,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$19.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.66776575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.912728,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,6.5,11,15.5,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.47,10.259347384615385,11.048694769230769,11.838042153846153,12.62738953846154,13.416736923076922,14.206084307692308,14.995431692307692,15.784779076923076,16.574126461538462,17.363473846153845,18.152821230769227,18.942168615384617,{"y":19.731516,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.47,10.177520442307692,10.885040884615385,11.592561326923077,12.30008176923077,13.007602211538462,13.715122653846155,14.422643096153847,15.130163538461538,15.837683980769231,16.545204423076925,17.252724865384614,17.960245307692308,{"y":18.66776575,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.47,10.042517538461539,10.615035076923078,11.187552615384616,11.760070153846154,12.332587692307694,12.905105230769232,13.47762276923077,14.05014030769231,14.622657846153848,15.195175384615386,15.767692923076925,16.34021046153846,{"y":16.912728,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.21,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.69,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.134,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.846,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.59,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.47,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$19.73Average Price Target$18.67Lowest Price Target$16.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Haywood Analyst forecast on TRLV
Neal Gilmer
Haywood
Haywood
$13.39→$16.91
Buy
173.23%
Upside
Reiterated
06/08/26
Haywood Sticks to Their Buy Rating for Trulieve Cannabis (TCNNF)
Roth MKM Analyst forecast on TRLV
Bill Kirk
Roth MKM
Roth MKM
$19
Buy
206.95%
Upside
Reiterated
06/05/26
Trulieve Cannabis (TCNNF) Gets a Buy from Roth MKM
Alliance Global Partners Analyst forecast on TRLV
Aaron Grey
Alliance Global Partners
Alliance Global Partners
$19.03
Buy
207.38%
Upside
Reiterated
06/04/26
Alliance Global says Trulieve Cannabis positioned well for NYSE listingAlliance Global says Trulieve Cannabis positioned well for NYSE listing
Canaccord Genuity Analyst forecast on TRLV
Luke Hannan
Canaccord Genuity
Canaccord Genuity
$19.73
Buy
218.76%
Upside
Reiterated
05/08/26
Canaccord Genuity Reaffirms Their Buy Rating on Trulieve Cannabis (TCNNF)
ATB Cormark Capital Markets Analyst forecast on TRLV
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$10.57
Buy
70.77%
Upside
Reiterated
02/27/26
Analysts' Top Healthcare Picks: Trulieve Cannabis (TCNNF), Medline (MDLN)
Beacon Analyst forecast on TRLV
Russell Stanley
Beacon
Beacon
$14.09
Buy
127.69%
Upside
Reiterated
12/22/25
This weed stock is a buy, analyst saysBeacon Securities analyst Russell Stanley reiterated his Buy rating and C$20.00 target on Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) on Dec. 17, after the company closed an upsized private placement of senior secured notes that Stanley said underscores strong investor demand and further strengthens the balance sheet.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Haywood Analyst forecast on TRLV
Neal Gilmer
Haywood
Haywood
$13.39→$16.91
Buy
173.23%
Upside
Reiterated
06/08/26
Haywood Sticks to Their Buy Rating for Trulieve Cannabis (TCNNF)
Roth MKM Analyst forecast on TRLV
Bill Kirk
Roth MKM
Roth MKM
$19
Buy
206.95%
Upside
Reiterated
06/05/26
Trulieve Cannabis (TCNNF) Gets a Buy from Roth MKM
Alliance Global Partners Analyst forecast on TRLV
Aaron Grey
Alliance Global Partners
Alliance Global Partners
$19.03
Buy
207.38%
Upside
Reiterated
06/04/26
Alliance Global says Trulieve Cannabis positioned well for NYSE listingAlliance Global says Trulieve Cannabis positioned well for NYSE listing
Canaccord Genuity Analyst forecast on TRLV
Luke Hannan
Canaccord Genuity
Canaccord Genuity
$19.73
Buy
218.76%
Upside
Reiterated
05/08/26
Canaccord Genuity Reaffirms Their Buy Rating on Trulieve Cannabis (TCNNF)
ATB Cormark Capital Markets Analyst forecast on TRLV
Frederico Gomes
ATB Cormark Capital Markets
ATB Cormark Capital Markets
$10.57
Buy
70.77%
Upside
Reiterated
02/27/26
Analysts' Top Healthcare Picks: Trulieve Cannabis (TCNNF), Medline (MDLN)
Beacon Analyst forecast on TRLV
Russell Stanley
Beacon
Beacon
$14.09
Buy
127.69%
Upside
Reiterated
12/22/25
This weed stock is a buy, analyst saysBeacon Securities analyst Russell Stanley reiterated his Buy rating and C$20.00 target on Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) on Dec. 17, after the company closed an upsized private placement of senior secured notes that Stanley said underscores strong investor demand and further strengthens the balance sheet.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Trulieve Cannabis

3 Months
Russell StanleyBeacon
Success Rate
9/16 ratings generated profit
56%
Average Return
+10.57%
Copying Russell Stanley's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +10.57% per trade.
1 Year
Russell StanleyBeacon
Success Rate
9/16 ratings generated profit
56%
Average Return
+55.00%
Copying Russell Stanley's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +55.00% per trade.
2 Years
Russell StanleyBeacon
Success Rate
11/16 ratings generated profit
69%
Average Return
+109.92%
Copying Russell Stanley's trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +109.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TRLV Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
4
2
2
2
4
Buy
0
0
0
1
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
2
2
3
6
In the current month, TRLV has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TRLV average Analyst price target in the past 3 months is 18.67.
Each month's total comprises the sum of three months' worth of ratings.

TRLV Financial Forecast

TRLV Earnings Forecast

Next quarter’s earnings estimate for TRLV is $0.08 with a range of $0.03 to $0.10. The previous quarter’s EPS was $0.01. TRLV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TRLV has Performed in-line its overall industry.
Next quarter’s earnings estimate for TRLV is $0.08 with a range of $0.03 to $0.10. The previous quarter’s EPS was $0.01. TRLV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TRLV has Performed in-line its overall industry.

TRLV Sales Forecast

Next quarter’s sales forecast for TRLV is $277.28M with a range of $268.00M to $293.20M. The previous quarter’s sales results were $286.75M. TRLV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TRLV has Performed in-line its overall industry.
Next quarter’s sales forecast for TRLV is $277.28M with a range of $268.00M to $293.20M. The previous quarter’s sales results were $286.75M. TRLV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TRLV has Performed in-line its overall industry.

TRLV Stock Forecast FAQ

What is TRLV’s average 12-month price target, according to analysts?
Based on analyst ratings, Trulieve Cannabis’s 12-month average price target is 18.67.
    What is TRLV’s upside potential, based on the analysts’ average price target?
    Trulieve Cannabis has 201.58% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TRLV a Buy, Sell or Hold?
          Trulieve Cannabis has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Trulieve Cannabis’s price target?
            The average price target for Trulieve Cannabis is 18.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $19.73 ,the lowest forecast is $16.91. The average price target represents 201.58% Increase from the current price of $6.19.
              What do analysts say about Trulieve Cannabis?
              Trulieve Cannabis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of TRLV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.